在NASH治疗中使用FXR激活剂
Luciano Adorini1, Michael Trauner2
1Intercept Pharmaceuticals Inc., 305 Madison Ave., Morristown, NJ 07960, USA.
Journal of hepatology
|August 10, 2023
概括
法内索伊德X受体 (FXR) 激动剂在治疗非酒精性脂肪肝炎 (NASH),一种严重的肝病方面表现有前途. 本综述检查了NASH治疗临床开发中的先进FXR激动剂.
科学领域:
- 肝病学和胃肠病学 肝病学和胃肠学
- 分子内分泌学分子内分泌学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非酒精性脂肪肝炎 (NASH) 是一种进展性肝病,没有经批准的治疗方法.
- 华氏体X受体 (FXR) 在调节肝脏和肠道功能,包括新陈代谢和炎症方面发挥着关键作用.
- FXR激活是NASH的有前途的治疗策略,因为它具有类作用.
研究的目的:
- 审查先进的Farnesoid X受体 (FXR) 激动剂的临床前和临床数据.
- 评估FXR激活剂在治疗非酒精性脂肪肝炎 (NASH) 的治疗潜力.
主要方法:
- 对涉及FXR激动剂的临床前研究和临床试验的文献综述.
- 基于它们的化学特性 (胆酸衍生物,类固醇,非类固醇,部分激动剂) 的FXR激动剂的分类.
- 批判性评估先进的FXR激动剂的疗效和安全性.
主要成果:
- 几种FXR激动剂,包括胆酸衍生物和非类固醇化合物,目前处于先进的临床开发阶段.
- 这些激动剂向涉及NASH病变发生的关键途径,如肥胖症,炎症和纤维化.
- 早期的临床数据表明潜在的疗效,但进一步的研究正在进行中.
结论:
- FXR激应剂代表了NASH的重要治疗机会.
- 不同类型的FXR激动剂为NASH治疗提供了各种各样的药理学特征.
- 持续的研究和临床试验对于确定FXR激动剂在NASH管理中的作用至关重要.
相关概念视频
01:25Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
01:31Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
01:30Adrenergic Agonists: Therapeutic Uses
841
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
841
01:28Drug-Receptor Interaction: Antagonist
3.1K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.1K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463